Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 95.72%170.7B | 139.32%114.57B | 193.11%56.25B | 53.64%124.59B | 58.29%87.21B | 72.99%47.87B | 44.20%19.19B | 3.64%81.09B | -6.02%55.1B | -28.55%27.68B |
| Refunds of taxes and levies | 341.80%2.93B | 606.94%2.52B | 870.33%1.5B | -9.87%923.27M | -19.67%664.22M | -43.52%356.65M | -58.78%154.47M | 6.39%1.02B | 7.35%826.88M | 15.62%631.41M |
| Cash received relating to other operating activities | 57.18%1.18B | -8.27%551.77M | -20.19%170.52M | 5.87%1.25B | 16.63%749.28M | -18.20%601.52M | -34.78%213.65M | 27.29%1.18B | 16.06%642.45M | 58.83%735.33M |
| Cash inflows from operating activities | 97.24%174.81B | 140.92%117.65B | 196.13%57.92B | 52.19%126.76B | 56.68%88.63B | 68.14%48.83B | 39.60%19.56B | 3.95%83.29B | -5.64%56.57B | -26.93%29.04B |
| Goods services cash paid | 96.03%181.44B | 140.49%119.57B | 138.61%50.61B | 56.16%119.77B | 60.31%92.56B | 59.81%49.72B | 71.16%21.21B | 6.90%76.7B | -6.95%57.73B | -34.41%31.11B |
| Staff behalf paid | 6.48%2.82B | 19.53%2.04B | -7.06%708.96M | 3.28%3.42B | 0.76%2.64B | -4.39%1.71B | 2.06%762.78M | -2.10%3.31B | 10.18%2.62B | 12.37%1.79B |
| All taxes paid | -22.65%835.67M | -33.83%488.56M | -50.32%242.72M | 59.47%1.11B | 124.14%1.08B | 123.60%738.37M | 125.63%488.53M | -33.23%698.28M | -42.92%481.99M | -39.82%330.22M |
| Cash paid relating to other operating activities | 29.70%2.29B | -6.46%1.12B | -7.24%563.08M | 14.15%2.36B | 32.93%1.77B | 21.41%1.2B | -14.95%607.02M | -3.64%2.07B | -3.26%1.33B | 16.87%988.68M |
| Cash outflows from operating activities | 91.12%187.38B | 130.90%123.22B | 125.95%52.12B | 53.03%126.67B | 57.71%98.05B | 55.96%53.37B | 63.96%23.07B | 5.69%82.77B | -6.72%62.17B | -32.13%34.22B |
| Net cash flows from operating activities | -33.48%-12.57B | -22.99%-5.58B | 265.48%5.8B | -81.18%97.96M | -68.16%-9.42B | 12.40%-4.53B | -6,038.91%-3.51B | -71.30%520.38M | 16.37%-5.6B | 51.51%-5.17B |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | -77.33%32.54M | --1M | ---- | ---- | -94.48%143.53M | ---- | ---- |
| Cash received from returns on investments | ---- | --0 | ---- | -81.24%802.97K | -98.58%802.97K | -64.55%15.6M | 323.47%5.85M | -80.60%4.28M | 452.66%56.74M | 357.77%44.01M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -83.47%5.27K | -82.48%5.27K | 642.30%5.27K | -99.02%166.65K | -99.81%31.89K | 1,176.65%30.08K | -69.86%710.21 | 326.99%17.06M | 6,307.95%17.06M | -99.40%2.36K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash received relating to other investing activities | --19.35M | --19.35M | ---- | --0 | --0 | --0 | ---- | --6.6M | ---- | ---- |
| Cash inflows from investing activities | 952.77%19.35M | 23.78%19.35M | -99.91%5.27K | -80.46%33.51M | -97.51%1.84M | -64.48%15.63M | 322.80%5.85M | -93.47%171.47M | -97.19%73.79M | -97.27%44.01M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 15.08%164.56M | -23.21%90.18M | -28.85%57.14M | -19.27%247.81M | -35.71%143M | -25.81%117.44M | 17.10%80.31M | -72.92%306.98M | -79.71%222.43M | -13.19%158.3M |
| Cash paid to acquire investments | 588.93%206.68M | --206.68M | --206.68M | 29.99%131.29M | -70.30%30M | --0 | ---- | -95.46%101M | -95.41%101M | -99.92%1M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --14.01M | ---- | ---- |
| Cash paid relating to other investing activities | -98.00%792K | --792K | --750K | -92.83%24M | -87.76%39.68M | --0 | ---- | --334.87M | 180,960.16%324.01M | 185,337.97%324.01M |
| Cash outflows from investing activities | 74.93%372.03M | 153.45%297.65M | 229.42%264.57M | -46.74%403.1M | -67.15%212.67M | -75.70%117.44M | 15.42%80.31M | -77.46%756.85M | -80.36%647.44M | -65.04%483.31M |
| Net cash flows from investing activities | -67.28%-352.68M | -173.36%-278.3M | -255.30%-264.56M | 36.86%-369.59M | 63.25%-210.83M | 76.83%-101.8M | -9.18%-74.46M | 19.99%-585.38M | 14.30%-573.65M | -293.11%-439.3M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | -15.64%133.21M | -15.64%133.21M | --133.21M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Cash from borrowing | 68.66%31.19B | 110.28%19.55B | 178.97%8.65B | 13.43%19.29B | 23.22%18.49B | -25.68%9.3B | -64.40%3.1B | -26.63%17.01B | -26.68%15.01B | -24.86%12.51B |
| Cash received relating to other financing activities | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash inflows from financing activities | 68.66%31.19B | 110.28%19.55B | 178.97%8.65B | 12.55%19.29B | 22.14%18.49B | -26.47%9.3B | -64.40%3.1B | -26.55%17.14B | -26.60%15.14B | -24.06%12.64B |
| Borrowing repayment | 47.33%14.61B | -18.66%6.11B | -18.83%3.54B | 80.37%22.49B | 22.80%9.92B | 32.91%7.51B | 22.91%4.37B | -43.33%12.47B | -32.47%8.07B | -2.18%5.65B |
| Dividend interest payment | 10.20%554.94M | -0.67%393.02M | 23.14%144.52M | -14.58%599.28M | -6.61%503.59M | 2.68%395.69M | 68.51%117.36M | -10.75%701.53M | -19.42%539.24M | -9.93%385.36M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 153.42%2.67M | 153.42%2.67M | ---- | ---- | -95.74%1.05M | -95.74%1.05M | ---- |
| Cash payments relating to other financing activities | 54.97%63.92M | -32.90%23.58M | 19.94%4.69M | -96.00%41.25M | 65.97%41.25M | 461.41%35.14M | -54.14%3.91M | 4,059.93%1.03B | 18.98%24.85M | -31.73%6.26M |
| Cash outflows from financing activities | 45.58%15.23B | -17.83%6.52B | -17.70%3.69B | 62.87%23.13B | 21.09%10.46B | 31.43%7.94B | 23.60%4.49B | -37.74%14.2B | -31.69%8.64B | -2.76%6.04B |
| Net cash flows from financing activities | 98.74%15.96B | 860.02%13.02B | 457.42%4.96B | -230.45%-3.84B | 23.53%8.03B | -79.45%1.36B | -127.31%-1.39B | 456.11%2.94B | -18.52%6.5B | -36.74%6.6B |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -1,329.25%-768.52M | -782.86%-528.76M | -804.96%-226.84M | -1,638.07%-529.18M | -142.58%-53.77M | 257.99%77.43M | 197.21%32.18M | -73.88%34.41M | 8.81%126.27M | -56.86%21.63M |
| Net increase in cash and cash equivalents | 236.82%2.26B | 307.45%6.64B | 308.02%10.27B | -259.34%-4.64B | -466.63%-1.65B | -417.37%-3.2B | -200.34%-4.94B | 67.01%2.91B | -37.91%451.25M | 2,391.78%1.01B |
| Add:Begin period cash and cash equivalents | -38.72%7.38B | -38.72%7.38B | -39.12%7.38B | 32.24%11.93B | 33.36%12.03B | 33.36%12.03B | 34.27%12.11B | 23.93%9.02B | 24.32%9.02B | 24.33%9.02B |
| End period cash equivalent | -7.14%9.64B | 58.67%14.02B | 145.78%17.64B | -38.85%7.3B | 9.55%10.38B | -11.95%8.83B | -48.51%7.18B | 32.24%11.93B | 18.66%9.48B | 37.45%10.03B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.